Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia

Detalhes bibliográficos
Autor(a) principal: Larré, Anne Brandolt
Data de Publicação: 2019
Tipo de documento: Tese
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da PUC_RS
Texto Completo: http://tede2.pucrs.br/tede2/handle/tede/8799
Resumo: Introduction: Phosphodiesterase is a cyclic nucleotide responsible for the hydrolysis of cyclic adenosine 3 ', 5'-monophosphate and / or cyclic guanosine monophosphate, which is important for clinical aspects. Phosphodiesterase activity is elevated in the serum of patients with Pre-Eclampsia Syndrome (SPE). This complex multisystemic syndrome remains with unknown etiology, its mechanisms are related to endothelial dysfunction and it covers a considerable fraction of pregnant women in the world. Objectives: In pregnant women with or without SPE: a) to compare the concentration of PDE5 protein in maternal plasma; b) to compare PDE5 enzymatic activity in the placenta; c) to compare placenta PDE5 mRNA expression. Methodology: Case-control study including 151 pregnant (100 controls and 51 with SPE). The concentration of PDE5 in maternal plasma was evaluated with an Enzyme Immunoadsorption Assay, enzymatic activity in the placenta was performed using a colorimetric assay and placental expression by qRT-PCR. Results: The concentration of PDE5 in maternal plasma was not different between groups (GC: 0.11 ± 0.04 ng / mL, SPE: 0.11 ± 0.01 ng / mL, p = 0.307, t Student). However, the expression of PDE5 in placental tissue was 1,125 times higher in SPE group (p> 0.001), with 0.1 being the minimum value and 5,454.9 being the maximum. The enzymatic activity of PDE was similar between groups (GC: 0.41 ± 0.28, SPE: 0.42 ± 0.26 nmol, p = 0.955, Mann Whitney test). Conclusion: Increased levels of PDE5 found in placenta may represent a pathophysiological event or adaptive phenomenon. Considering the normal levels of the enzyme in SPE plasma and high expression in placentas of the same group - it is suggested that the placenta plays a central role in SPE physiology. The alterations associated with PDE5 in SPE suggest that this enzyme has a relevant role in the pathophysiological processes associated with the vasoconstriction presented by these women.
id P_RS_ed7a37802f6dbcecc20f54fe110ee4ed
oai_identifier_str oai:tede2.pucrs.br:tede/8799
network_acronym_str P_RS
network_name_str Biblioteca Digital de Teses e Dissertações da PUC_RS
repository_id_str
spelling Figueiredo, Carlos Eduardo Poli dehttp://lattes.cnpq.br/7183837354797239http://lattes.cnpq.br/9850221103563340Larré, Anne Brandolt2019-07-12T18:15:02Z2019-03-25http://tede2.pucrs.br/tede2/handle/tede/8799Introduction: Phosphodiesterase is a cyclic nucleotide responsible for the hydrolysis of cyclic adenosine 3 ', 5'-monophosphate and / or cyclic guanosine monophosphate, which is important for clinical aspects. Phosphodiesterase activity is elevated in the serum of patients with Pre-Eclampsia Syndrome (SPE). This complex multisystemic syndrome remains with unknown etiology, its mechanisms are related to endothelial dysfunction and it covers a considerable fraction of pregnant women in the world. Objectives: In pregnant women with or without SPE: a) to compare the concentration of PDE5 protein in maternal plasma; b) to compare PDE5 enzymatic activity in the placenta; c) to compare placenta PDE5 mRNA expression. Methodology: Case-control study including 151 pregnant (100 controls and 51 with SPE). The concentration of PDE5 in maternal plasma was evaluated with an Enzyme Immunoadsorption Assay, enzymatic activity in the placenta was performed using a colorimetric assay and placental expression by qRT-PCR. Results: The concentration of PDE5 in maternal plasma was not different between groups (GC: 0.11 ± 0.04 ng / mL, SPE: 0.11 ± 0.01 ng / mL, p = 0.307, t Student). However, the expression of PDE5 in placental tissue was 1,125 times higher in SPE group (p> 0.001), with 0.1 being the minimum value and 5,454.9 being the maximum. The enzymatic activity of PDE was similar between groups (GC: 0.41 ± 0.28, SPE: 0.42 ± 0.26 nmol, p = 0.955, Mann Whitney test). Conclusion: Increased levels of PDE5 found in placenta may represent a pathophysiological event or adaptive phenomenon. Considering the normal levels of the enzyme in SPE plasma and high expression in placentas of the same group - it is suggested that the placenta plays a central role in SPE physiology. The alterations associated with PDE5 in SPE suggest that this enzyme has a relevant role in the pathophysiological processes associated with the vasoconstriction presented by these women.Introdução: A fosfodiesterase é um nucleotídeo cíclico responsável pela hidrólise de adenosina 3',5'-monofosfato cíclico e/ou monofosfato cíclico de guanosina, que apresenta grande importância clínica. A atividade da fosfodiesterase está elevada no soro de pacientes com Síndrome de Pré-Eclâmpsia (SPE). Essa síndrome multissistêmica e complexa permanece com etiologia desconhecida, seus mecanismos estão relacionados com disfunção endotelial e abrange uma parcela considerável de gestantes no mundo. Objetivos: Em gestantes com ou sem SPE: a) comparar a concentração da proteína PDE5 no sangue materno; b) comparar a atividade enzimática da PDE5 na placenta; c) comparar a expressão de mRNA da PDE5 na placenta. Metodologia: Estudo de caso-controle incluindo 151 pacientes (100 controles (GC) e 51 com SPE). A concentração de PDE5 no plasma materno foi avaliada com um Ensaio de Imunoadsorção Enzimática, a atividade enzimática na placenta foi realizada utilizando um ensaio colorimétrico e a expressão placentária por qRT-PCR. Resultados: A concentração de PDE5 no plasma materno não foi significativamente diferente entre os grupos (GC: 0,11 ± 0,04 ng / mL; PE: 0,11 ± 0,01 ng / mL, p = 0,307, Teste t de Student). No entanto, a expressão de PDE5 no tecido placentário foi 1,125 vezes maior no grupo com SPE (p> 0,001), sendo 0,1 o valor mínimo e 5,454,9 o máximo. A atividade enzimática da PDE foi semelhante entre os dois grupos (NC: 0,41 ± 0,28; PE: 0,42 ± 0,26 nmol; p = 0,955; teste de Mann Whitney). Conclusão: Os níveis de PDE5 encontrados aumentados na placenta podem representar um evento fisiopatológico ou fenômeno adaptativo. Considerando-se os níveis normais da enzima no plasma das pacientes com SPE e a expressão elevada nas placentas das mesmas- sugere-se que a placenta tenha um papel central na fisiologia da SPE. As alterações associadas à PDE5 na SPE sugerem que esta enzima tenha um papel relevante nos processos fisiopatológicos associados à vasoconstrição apresentada por estas mulheres.Submitted by PPG Medicina e Ciências da Saúde (medicina-pg@pucrs.br) on 2019-07-04T18:49:07Z No. of bitstreams: 1 Anne_Brandolt_Larré.pdf: 2730543 bytes, checksum: 79d9a4bfee1bf55bb97eaa6e9513172c (MD5)Rejected by Sarajane Pan (sarajane.pan@pucrs.br), reason: Devolvido devido a falta da capa institucional no arquivo PDF. on 2019-07-05T14:27:12Z (GMT)Submitted by PPG Medicina e Ciências da Saúde (medicina-pg@pucrs.br) on 2019-07-11T13:24:52Z No. of bitstreams: 1 Anne_Brandolt_Larré.pdf: 2431111 bytes, checksum: 06dc4032c19ed0e890914a2453f1f41d (MD5)Approved for entry into archive by Sarajane Pan (sarajane.pan@pucrs.br) on 2019-07-12T18:09:18Z (GMT) No. of bitstreams: 1 Anne_Brandolt_Larré.pdf: 2431111 bytes, checksum: 06dc4032c19ed0e890914a2453f1f41d (MD5)Made available in DSpace on 2019-07-12T18:15:02Z (GMT). No. of bitstreams: 1 Anne_Brandolt_Larré.pdf: 2431111 bytes, checksum: 06dc4032c19ed0e890914a2453f1f41d (MD5) Previous issue date: 2019-03-25Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPqapplication/pdfhttp://tede2.pucrs.br:80/tede2/retrieve/175944/TES_ANNE_BRANDOLT_LARR%c3%89_CONFIDENCIAL.pdf.jpgporPontifícia Universidade Católica do Rio Grande do SulPrograma de Pós-Graduação em Medicina e Ciências da SaúdePUCRSBrasilEscola de MedicinaFosfodiesterasesVasoconstriçãoHipertensãoProteinúriaPlacentaPhosphodiesterasesVasoconstrictionHypertensionProteinuriaPlacentaCIENCIAS DA SAUDE::MEDICINAFosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsiainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisTrabalho será publicado como artigo ou livro60 meses12/07/2024-721401722658532398500500500600-224747486637135387-9693694523087866271802873727776104890info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da PUC_RSinstname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)instacron:PUC_RSORIGINALTES_ANNE_BRANDOLT_LARRÉ_CONFIDENCIAL.pdfTES_ANNE_BRANDOLT_LARRÉ_CONFIDENCIAL.pdfapplication/pdf556736http://tede2.pucrs.br/tede2/bitstream/tede/8799/7/TES_ANNE_BRANDOLT_LARR%C3%89_CONFIDENCIAL.pdf888f5fcbbc381249308797179f611e4fMD57THUMBNAILTES_ANNE_BRANDOLT_LARRÉ_CONFIDENCIAL.pdf.jpgTES_ANNE_BRANDOLT_LARRÉ_CONFIDENCIAL.pdf.jpgimage/jpeg4086http://tede2.pucrs.br/tede2/bitstream/tede/8799/6/TES_ANNE_BRANDOLT_LARR%C3%89_CONFIDENCIAL.pdf.jpgcc4e058a1dddb0d648f03aefddaa0f5fMD56TEXTTES_ANNE_BRANDOLT_LARRÉ_CONFIDENCIAL.pdf.txtTES_ANNE_BRANDOLT_LARRÉ_CONFIDENCIAL.pdf.txttext/plain1871http://tede2.pucrs.br/tede2/bitstream/tede/8799/5/TES_ANNE_BRANDOLT_LARR%C3%89_CONFIDENCIAL.pdf.txtacc4e83d86859556035874ebd17107ccMD55LICENSElicense.txtlicense.txttext/plain; charset=utf-8590http://tede2.pucrs.br/tede2/bitstream/tede/8799/3/license.txt220e11f2d3ba5354f917c7035aadef24MD53tede/87992019-10-21 15:38:27.959oai:tede2.pucrs.br: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Biblioteca Digital de Teses e Dissertaçõeshttp://tede2.pucrs.br/tede2/PRIhttps://tede2.pucrs.br/oai/requestbiblioteca.central@pucrs.br||opendoar:2019-10-21T17:38:27Biblioteca Digital de Teses e Dissertações da PUC_RS - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)false
dc.title.por.fl_str_mv Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia
title Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia
spellingShingle Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia
Larré, Anne Brandolt
Fosfodiesterases
Vasoconstrição
Hipertensão
Proteinúria
Placenta
Phosphodiesterases
Vasoconstriction
Hypertension
Proteinuria
Placenta
CIENCIAS DA SAUDE::MEDICINA
title_short Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia
title_full Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia
title_fullStr Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia
title_full_unstemmed Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia
title_sort Fosfodiesterase isoforma tipo 5 na síndrome de pré-eclâmpsia
author Larré, Anne Brandolt
author_facet Larré, Anne Brandolt
author_role author
dc.contributor.advisor1.fl_str_mv Figueiredo, Carlos Eduardo Poli de
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/7183837354797239
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/9850221103563340
dc.contributor.author.fl_str_mv Larré, Anne Brandolt
contributor_str_mv Figueiredo, Carlos Eduardo Poli de
dc.subject.por.fl_str_mv Fosfodiesterases
Vasoconstrição
Hipertensão
Proteinúria
Placenta
topic Fosfodiesterases
Vasoconstrição
Hipertensão
Proteinúria
Placenta
Phosphodiesterases
Vasoconstriction
Hypertension
Proteinuria
Placenta
CIENCIAS DA SAUDE::MEDICINA
dc.subject.eng.fl_str_mv Phosphodiesterases
Vasoconstriction
Hypertension
Proteinuria
Placenta
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::MEDICINA
description Introduction: Phosphodiesterase is a cyclic nucleotide responsible for the hydrolysis of cyclic adenosine 3 ', 5'-monophosphate and / or cyclic guanosine monophosphate, which is important for clinical aspects. Phosphodiesterase activity is elevated in the serum of patients with Pre-Eclampsia Syndrome (SPE). This complex multisystemic syndrome remains with unknown etiology, its mechanisms are related to endothelial dysfunction and it covers a considerable fraction of pregnant women in the world. Objectives: In pregnant women with or without SPE: a) to compare the concentration of PDE5 protein in maternal plasma; b) to compare PDE5 enzymatic activity in the placenta; c) to compare placenta PDE5 mRNA expression. Methodology: Case-control study including 151 pregnant (100 controls and 51 with SPE). The concentration of PDE5 in maternal plasma was evaluated with an Enzyme Immunoadsorption Assay, enzymatic activity in the placenta was performed using a colorimetric assay and placental expression by qRT-PCR. Results: The concentration of PDE5 in maternal plasma was not different between groups (GC: 0.11 ± 0.04 ng / mL, SPE: 0.11 ± 0.01 ng / mL, p = 0.307, t Student). However, the expression of PDE5 in placental tissue was 1,125 times higher in SPE group (p> 0.001), with 0.1 being the minimum value and 5,454.9 being the maximum. The enzymatic activity of PDE was similar between groups (GC: 0.41 ± 0.28, SPE: 0.42 ± 0.26 nmol, p = 0.955, Mann Whitney test). Conclusion: Increased levels of PDE5 found in placenta may represent a pathophysiological event or adaptive phenomenon. Considering the normal levels of the enzyme in SPE plasma and high expression in placentas of the same group - it is suggested that the placenta plays a central role in SPE physiology. The alterations associated with PDE5 in SPE suggest that this enzyme has a relevant role in the pathophysiological processes associated with the vasoconstriction presented by these women.
publishDate 2019
dc.date.accessioned.fl_str_mv 2019-07-12T18:15:02Z
dc.date.issued.fl_str_mv 2019-03-25
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://tede2.pucrs.br/tede2/handle/tede/8799
url http://tede2.pucrs.br/tede2/handle/tede/8799
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv -721401722658532398
dc.relation.confidence.fl_str_mv 500
500
500
600
dc.relation.department.fl_str_mv -224747486637135387
dc.relation.cnpq.fl_str_mv -969369452308786627
dc.relation.sponsorship.fl_str_mv 1802873727776104890
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Pontifícia Universidade Católica do Rio Grande do Sul
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Medicina e Ciências da Saúde
dc.publisher.initials.fl_str_mv PUCRS
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Escola de Medicina
publisher.none.fl_str_mv Pontifícia Universidade Católica do Rio Grande do Sul
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da PUC_RS
instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron:PUC_RS
instname_str Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron_str PUC_RS
institution PUC_RS
reponame_str Biblioteca Digital de Teses e Dissertações da PUC_RS
collection Biblioteca Digital de Teses e Dissertações da PUC_RS
bitstream.url.fl_str_mv http://tede2.pucrs.br/tede2/bitstream/tede/8799/7/TES_ANNE_BRANDOLT_LARR%C3%89_CONFIDENCIAL.pdf
http://tede2.pucrs.br/tede2/bitstream/tede/8799/6/TES_ANNE_BRANDOLT_LARR%C3%89_CONFIDENCIAL.pdf.jpg
http://tede2.pucrs.br/tede2/bitstream/tede/8799/5/TES_ANNE_BRANDOLT_LARR%C3%89_CONFIDENCIAL.pdf.txt
http://tede2.pucrs.br/tede2/bitstream/tede/8799/3/license.txt
bitstream.checksum.fl_str_mv 888f5fcbbc381249308797179f611e4f
cc4e058a1dddb0d648f03aefddaa0f5f
acc4e83d86859556035874ebd17107cc
220e11f2d3ba5354f917c7035aadef24
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da PUC_RS - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
repository.mail.fl_str_mv biblioteca.central@pucrs.br||
_version_ 1799765341151166464